🚀 VC round data is live in beta, check it out!
SynBiotic Valuation Multiples
Discover revenue and EBITDA valuation multiples for SynBiotic and similar public comparables like The Cannabist Company, iAnthus Capital Holdings, MariMed, Ayr Wellness and more.
SynBiotic Overview
About SynBiotic
SynBiotic SE is engaged in the development of Phyto-cannabinoids and other herbal compounds concentrated molecules as well as the development of wellness products. The company engages in synthetic production, drug development, cannabinoids, dietary supplements and cosmetic products. Geographical presence in Germany, Austria, UK, Switzerland and Other countries. Majority of its revenue comes from domestic market.
Founded
2015
HQ
Employees
103
Website
Financials (FY)
EV
$21M
SynBiotic Financials
SynBiotic reported last fiscal year revenue of $17M and negative EBITDA of ($2M).
In the same fiscal year, SynBiotic generated $6M in gross profit, ($2M) in EBITDA losses, and had net loss of ($11M).
Revenue (LTM)
SynBiotic P&L
In the most recent fiscal year, SynBiotic reported revenue of $17M and EBITDA of ($2M).
SynBiotic expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $17M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $6M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 34% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($2M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (14%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (74%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($11M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (68%) | XXX | XXX | XXX |
| Net Debt | — | — | $5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
SynBiotic Stock Performance
SynBiotic has current market cap of $17M, and enterprise value of $21M.
Market Cap Evolution
SynBiotic's stock price is $2.22.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $21M | $17M | -1.2% | XXX | XXX | XXX | $-1.49 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSynBiotic Valuation Multiples
SynBiotic trades at 1.2x EV/Revenue multiple, and (8.6x) EV/EBITDA.
EV / Revenue (LTM)
SynBiotic Financial Valuation Multiples
As of April 15, 2026, SynBiotic has market cap of $17M and EV of $21M.
Equity research analysts estimate SynBiotic's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
SynBiotic has a P/E ratio of (1.5x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $17M | XXX | $17M | XXX | XXX | XXX |
| EV (current) | $21M | XXX | $21M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.2x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (8.6x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (1.7x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.6x | XXX | XXX | XXX |
| P/E | — | XXX | (1.5x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (24.0x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified SynBiotic Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
SynBiotic Margins & Growth Rates
SynBiotic's revenue in the last fiscal year grew by 270%.
SynBiotic's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
SynBiotic Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 270% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (14%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (72%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 5% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 8% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 108% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
SynBiotic Public Comps
See public comps and valuation multiples for other Cannabis comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| SynBiotic | XXX | XXX | XXX | XXX | XXX | XXX |
| The Cannabist Company | XXX | XXX | XXX | XXX | XXX | XXX |
| iAnthus Capital Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| MariMed | XXX | XXX | XXX | XXX | XXX | XXX |
| Ayr Wellness | XXX | XXX | XXX | XXX | XXX | XXX |
| Bakhu Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
SynBiotic M&A Activity
SynBiotic acquired XXX companies to date.
Last acquisition by SynBiotic was on XXXXXXXX, XXXXX. SynBiotic acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by SynBiotic
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSynBiotic Investment Activity
SynBiotic invested in XXX companies to date.
SynBiotic made its latest investment on XXXXXXXX, XXXXX. SynBiotic invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by SynBiotic
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout SynBiotic
| When was SynBiotic founded? | SynBiotic was founded in 2015. |
| Where is SynBiotic headquartered? | SynBiotic is headquartered in Germany. |
| How many employees does SynBiotic have? | As of today, SynBiotic has over 103 employees. |
| Is SynBiotic publicly listed? | Yes, SynBiotic is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of SynBiotic? | SynBiotic trades under SBX ticker. |
| When did SynBiotic go public? | SynBiotic went public in 2021. |
| Who are competitors of SynBiotic? | SynBiotic main competitors are The Cannabist Company, iAnthus Capital Holdings, MariMed, Ayr Wellness. |
| What is the current market cap of SynBiotic? | SynBiotic's current market cap is $17M. |
| What is the current revenue of SynBiotic? | SynBiotic's last fiscal year revenue is $17M. |
| What is the current EV/Revenue multiple of SynBiotic? | Current revenue multiple of SynBiotic is 1.2x. |
| Is SynBiotic profitable? | No, SynBiotic is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.